Brain Tumors Clinical Trials

NLG2102

Study of IDO Inhibitor and Temozolomide for adult patients with primary malignant brain tumors. Click here to learn more.

EMR200647-001

A Phase I, Open-label, Multiple-ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of MSB0011359C in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications. Click here to learn more.

 

 

 

 

 

 

 

 

 

 

 

UCBC